{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:10:28Z","timestamp":1790820628775,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["K12 HS026370"],"award-info":[{"award-number":["K12 HS026370"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008309","name":"Johns Hopkins Bloomberg School of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008309","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.dadr.2024.100255","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T09:36:44Z","timestamp":1720949804000},"page":"100255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Association of economic and racial segregation with restricted buprenorphine dispensing in U.S. community pharmacies"],"prefix":"10.1016","volume":"12","author":[{"given":"Kyle J.","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabriya L.","family":"Linton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda J.","family":"Kazerouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena A.","family":"Levander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriane N.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2024.100255_bib1","unstructured":"ACS and COVID-19: Guidance for using the PUMS with experimental weights, 2022. Integrated Public Use Microdata Series USA. \u3008https:\/\/usa.ipums.org\/usa\/acspumscovid19.shtml\u3009 (accessed 4.22.24)."},{"key":"10.1016\/j.dadr.2024.100255_bib2","unstructured":"ACS Table B03002: Hispanic or Latino Origin by Race, 2020. U.S. Census Bureau. \u3008https:\/\/data.census.gov\/table\/ACSDT5Y2020.B03002?q=B03002:%20HISPANIC%20OR%20LATINO%20ORIGIN%20BY%20RACE&g=010XX00US$0500000\u3009 (accessed 10.4.23)."},{"key":"10.1016\/j.dadr.2024.100255_bib3","unstructured":"ACS Table B19001: Household Income in the Past 12 Months, 2020. U.S. Census Bureau. \u3008https:\/\/data.census.gov\/table?q=B19001:%20HOUSEHOLD%20INCOME%20IN%20THE%20PAST%2012%20MONTHS%20\u3009(IN%202020%20INFLATION-ADJUSTED%20DOLLARS)&g=010XX00US$0500000 (accessed 10.4.23)."},{"key":"10.1016\/j.dadr.2024.100255_bib4","unstructured":"ACS Table B19001B: Household Income in the Past 12 Months for Black or African American Alone Householder, 2020. U.S. Census Bureau. \u3008https:\/\/data.census.gov\/table\/ACSDT5Y2020.B19001B?q=B19001B:%20Household%20Income%20in%20the%20Past%2012%20Months%20\u3009(in%202022%20Inflation-Adjusted%20Dollars)%20(Black%20or%20African%20American%20Alone%20Householder)&g=010XX00US$0500000&tid=ACSDT1Y2022.B19001B (accessed 10.4.23)."},{"key":"10.1016\/j.dadr.2024.100255_bib5","unstructured":"ACS Table B19001H: Household Income in the Past 12 Months for White Alone, Not Hispanic or Latino Householder, 2020. U.S. Census Bureau. \u3008https:\/\/data.census.gov\/table\/ACSDT5Y2020.B19001H?q=B19001H:%20Household%20Income%20in%20the%20Past%2012%20Months%20\u3009(in%202022%20Inflation-Adjusted%20Dollars)%20(White%20Alone,%20Not%20Hispanic%20or%20Latino%20Householder)&g=010XX00US$0500000 (accessed 10.4.23)."},{"key":"10.1016\/j.dadr.2024.100255_bib6","unstructured":"ACS Table B19001I: Household Income in the Past 12 Months for Hispanic or Latino Householder, 2020. U.S. Census Bureau. \u3008https:\/\/data.census.gov\/table\/ACSDT5Y2020.B19001I?q=B19001I:%20HOUSEHOLD%20INCOME%20IN%20THE%20PAST%2012%20MONTHS%20\u3009(IN%202020%20INFLATION-ADJUSTED%20DOLLARS)%20(HISPANIC%20OR%20LATINO%20HOUSEHOLDER)&g=010XX00US$0500000 (accessed 10.4.23)."},{"key":"10.1016\/j.dadr.2024.100255_bib7","unstructured":"ACS Table B19080: Household Income Quintile Upper Limits, 2020. U.S. Census Bureau. \u3008https:\/\/data.census.gov\/table\/ACSDT5Y2020.B19080?q=B19080&g=010XX00US$0500000\u3009 (accessed 10.4.23)."},{"key":"10.1016\/j.dadr.2024.100255_bib8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2105\/AJPH.2020.305610","article-title":"Future directions for incorporating intersectionality into quantitative population health research","volume":"110","author":"Ag\u00e9nor","year":"2020","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.dadr.2024.100255_bib10","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMsa2212412","article-title":"Racial inequality in receipt of medications for opioid use disorder","volume":"388","author":"Barnett","year":"2023","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.dadr.2024.100255_bib11","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s11606-018-4801-3","article-title":"Methadone matters: what the United States Can Learn from the Global Effort to Treat Opioid Addiction","volume":"34","author":"Calcaterra","year":"2019","journal-title":"J. Gen. Intern Med"},{"key":"10.1016\/j.dadr.2024.100255_bib12","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.21105\/joss.03544","article-title":"tidygeocoder: an R package for geocoding","volume":"6","author":"Cambon","year":"2021","journal-title":"J. Open Source Softw."},{"key":"10.1016\/j.dadr.2024.100255_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1215\/03616878-10041135","article-title":"Pursuing pharmacoequity: determinants, drivers, and pathways to progress","volume":"47","author":"Chalasani","year":"2022","journal-title":"J. Health Polit. Policy Law"},{"key":"10.1016\/j.dadr.2024.100255_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11524-018-0272-4","article-title":"Using Index of Concentration at the Extremes as Indicators of Structural Racism to Evaluate the Association with Preterm Birth and Infant Mortality\u2014California, 2011\u20132012","volume":"96","author":"Chambers","year":"2019","journal-title":"J. Urban Health"},{"key":"10.1016\/j.dadr.2024.100255_bib15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2146\/ajhp150872","article-title":"Evaluation of racial and socioeconomic disparities in medication pricing and pharmacy access and services","volume":"74","author":"Chisholm-Burns","year":"2017","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.dadr.2024.100255_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis","volume":"71","author":"Ciccarone","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100255_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102701","article-title":"Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: a case study of the rural risk environment in Appalachian Kentucky","volume":"85","author":"Cooper","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100255_bib18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1056\/NEJMp2002908","article-title":"When Prescribing Isn\u2019t Enough \u2014 Pharmacy-Level Barriers to Buprenorphine Access","volume":"383","author":"Cooper","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.dadr.2024.100255_bib19","unstructured":"DataQ, a product of NCPDP [WWW Document], n.d. National Council for Prescription Drug Programs. URL \u3008https:\/\/dataq.ncpdp.org\/\u3009 (accessed 10.4.23)."},{"key":"10.1016\/j.dadr.2024.100255_bib20","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/aje\/kwac112","article-title":"What Structural Racism Is (or Is Not) and How to Measure It: clarity for public health and medical researchers","volume":"191","author":"Dean","year":"2022","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.dadr.2024.100255_bib21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1001\/archinte.1966.00290160004002","article-title":"Narcotic blockade","volume":"118","author":"Dole","year":"1966","journal-title":"Arch. Intern Med"},{"key":"10.1016\/j.dadr.2024.100255_bib22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.amepre.2022.05.006","article-title":"Racial\u2013ethnic disparities of buprenorphine and vivitrol receipt in Medicaid","volume":"63","author":"Dunphy","year":"2022","journal-title":"Am. J. Prev. Med"},{"key":"10.1016\/j.dadr.2024.100255_bib23","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1001\/jama.2021.17764","article-title":"A policy prescription for reducing health disparities\u2014achieving pharmacoequity","volume":"326","author":"Essien","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.dadr.2024.100255_bib24","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/jech-2015-205728","article-title":"Spatial social polarisation: using the Index of Concentration at the Extremes jointly for income and race\/ethnicity to analyse risk of hypertension","volume":"69","author":"Feldman","year":"2015","journal-title":"J. Epidemiol. Community Health (1978)"},{"key":"10.1016\/j.dadr.2024.100255_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamapsychiatry.2018.3685","article-title":"Buprenorphine deregulation and mainstreaming treatment for opioid use disorder","volume":"76","author":"Fiscella","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.dadr.2024.100255_bib26","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.2105\/AJPH.2021.306256","article-title":"COVID-19 and the Drug Overdose Crisis: uncovering the Deadliest Months in the United States, January-July 2020","volume":"111","author":"Friedman","year":"2021","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.dadr.2024.100255_bib27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1176\/appi.ajp.2021.21040381","article-title":"Surging racial disparities in the U.S. Overdose Crisis","volume":"179","author":"Friedman","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.dadr.2024.100255_bib28","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/jamapsychiatry.2021.0967","article-title":"Racial\/Ethnic, social, and geographic trends in overdose-associated cardiac arrests observed by us emergency medical services during the COVID-19 pandemic","volume":"78","author":"Friedman","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.dadr.2024.100255_bib29","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/add.16318","article-title":"Charting the fourth wave: geographic, temporal, race\/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010\u20132021","volume":"118","author":"Friedman","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2024.100255_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.36298","article-title":"Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic","volume":"5","author":"Frost","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2024.100255_bib31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of Racial\/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States","volume":"3","author":"Goedel","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2024.100255_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.22303","article-title":"Trends in Opioid Toxicity\u2013Related Deaths in the US Before and After the Start of the COVID-19 Pandemic, 2011-2021","volume":"6","author":"Gomes","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2024.100255_bib33","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/08897077.2021.2010162","article-title":"Commentary article: study protocol for the respond to prevent study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies","volume":"43","author":"Green","year":"2022","journal-title":"Subst. Abus"},{"key":"10.1016\/j.dadr.2024.100255_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2021.07.009","article-title":"Access to pharmacies and pharmacy services in New York City, Los Angeles, Chicago, and Houston, 2015-2020","volume":"61","author":"Guadamuz","year":"2021","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.dadr.2024.100255_bib35","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2105\/AJPH.2016.303483","article-title":"Is the prescription opioid epidemic a white problem?","volume":"106","author":"Hansen","year":"2016","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.dadr.2024.100255_bib36","doi-asserted-by":"crossref","unstructured":"Hansen, H., Netherland, J., Herzberg, D., 2023. Whiteout: How racial capitalism changed the color of opioids in America. University of California Press. https:\/\/doi.org\/10.1525\/9780520384071","DOI":"10.1525\/9780520384071"},{"key":"10.1016\/j.dadr.2024.100255_bib37","series-title":"Critical Perspectives on Addiction","first-page":"79","article-title":"Two Tiers of Biomedicalization: Methadone, Buprenorphine, and the Racial Politics of Addiction Treatment","author":"Hansen","year":"2012"},{"key":"10.1016\/j.dadr.2024.100255_bib38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City","volume":"40","author":"Hansen","year":"2013","journal-title":"J. Behav. Health Serv. Res"},{"key":"10.1016\/j.dadr.2024.100255_bib39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10826084.2017.1385633","article-title":"At the expense of a life: race, class, and the meaning of buprenorphine in pharmaceuticalized \u201ccare\u201d","volume":"53","author":"Hatcher","year":"2018","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.dadr.2024.100255_bib40","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.japh.2022.08.017","article-title":"Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: a national survey of community-based pharmacists","volume":"63","author":"Hill","year":"2023","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.dadr.2024.100255_bib41","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/add.15314","article-title":"Availability of buprenorphine\/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA","volume":"116","author":"Hill","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.dadr.2024.100255_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109518","article-title":"Availability of buprenorphine\/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states","volume":"237","author":"Hill","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100255_bib43","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-023-08382-2","article-title":"Mobilizing primary care against the opioid crisis in the post X-Waiver Era","author":"Incze","year":"2023","journal-title":"J. Gen. Intern Med"},{"key":"10.1016\/j.dadr.2024.100255_bib44","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.japh.2022.12.001","article-title":"Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician","volume":"63","author":"Irwin","year":"2023","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.dadr.2024.100255_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mcna.2021.08.008","article-title":"Disparities in addiction treatment","volume":"106","author":"Jackson","year":"2022","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.dadr.2024.100255_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107968","article-title":"Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: a cross-sectional study","volume":"211","author":"Joudrey","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100255_bib48","article-title":"Methadone prescribing by addiction specialists likely to leave communities without available methadone treatment","volume":"1","author":"Joudrey","year":"2023","journal-title":"Health Aff. Sch."},{"key":"10.1016\/j.dadr.2024.100255_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108729","article-title":"Pharmacy-related buprenorphine access barriers: an audit of pharmacies in counties with a high opioid overdose burden","volume":"224","author":"Kazerouni","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100255_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019\u201d","volume":"110","author":"Krawczyk","year":"2022","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100255_bib51","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/ije\/dyy004","article-title":"Using the Index of Concentration at the Extremes at multiple geographical levels to monitor health inequities in an era of growing spatial social polarization: Massachusetts, USA (2010\u201314)","volume":"47","author":"Krieger","year":"2018","journal-title":"Int J. Epidemiol."},{"key":"10.1016\/j.dadr.2024.100255_bib52","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2105\/AJPH.2015.302955","article-title":"Public health monitoring of privilege and deprivation with the index of concentration at the extremes","volume":"106","author":"Krieger","year":"2016","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.dadr.2024.100255_bib53","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","article-title":"Buprenorphine treatment divide by race\/ethnicity and payment","volume":"76","author":"Lagisetty","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.dadr.2024.100255_bib54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/ajad.12925","article-title":"Low-Barrier Buprenorphine Initiation Predicts Treatment Retention Among Latinx and Non-Latinx Primary Care Patients","volume":"28","author":"Lee","year":"2019","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.dadr.2024.100255_bib55","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1176\/appi.ps.202100122","article-title":"Advanced practice providers and buprenorphine access in the United States after the comprehensive addiction and recovery act","volume":"72","author":"Lee","year":"2021","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.dadr.2024.100255_bib56","doi-asserted-by":"crossref","DOI":"10.1177\/29767342231215178","article-title":"Relationships between stigma, risk tolerance, and buprenorphine dispensing intentions among community-based pharmacists: results from a national sample","author":"Light","year":"2024","journal-title":"Subst. Use Addict. J."},{"key":"10.1016\/j.dadr.2024.100255_bib57","article-title":"Factors in rural community buprenorphine dispensing","volume":"9","author":"Major","year":"2023","journal-title":"Explor. Res. Clin. Soc. Pharm."},{"key":"10.1016\/j.dadr.2024.100255_bib58","unstructured":"Markey, E.J., 2023. S.644 - Modernizing Opioid Treatment Access Act. 118th Congress, Washington, D.C."},{"key":"10.1016\/j.dadr.2024.100255_bib59","series-title":"Does It Take A Village? Community Effects on Children, Adolescents, and Families","first-page":"41","article-title":"The prodigal paradigm returns: Ecology comes back to Sociology","author":"Massey","year":"2001"},{"key":"10.1016\/j.dadr.2024.100255_bib60","unstructured":"Milgram, A.M., Levine, R.L., Delphin-Rittmon, M.E., 2023. https:\/\/www.deadiversion.usdoj.gov\/pubs\/docs\/Dear_Registrant_MOUD.pdf"},{"key":"10.1016\/j.dadr.2024.100255_bib61","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/ADM.0000000000000762","article-title":"DEA Disconnect Leads to Buprenorphine Bottlenecks","volume":"15","author":"Ostrach","year":"2021","journal-title":"J. Addict. Med"},{"key":"10.1016\/j.dadr.2024.100255_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198173","article-title":"Mapping pharmacy deserts and determining accessibility to community pharmacy services for elderly enrolled in a State Pharmaceutical Assistance Program","volume":"13","author":"Pednekar","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.dadr.2024.100255_bib63","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1377\/hlthaff.2013.1397","article-title":"Pharmacy Deserts\u2019 Are Prevalent In Chicago\u2019s Predominantly Minority Communities, Raising Medication Access Concerns","volume":"33","author":"Qato","year":"2014","journal-title":"Health Aff."},{"key":"10.1016\/j.dadr.2024.100255_bib64","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2022.2839","article-title":"Federal and State Pharmacy Regulations and Dispensing Barriers to Buprenorphine Access at Retail Pharmacies in the US","volume":"3","author":"Qato","year":"2022","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.dadr.2024.100255_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.109859","article-title":"US drug overdose mortality rose faster among hispanics than non-hispanics from 2010 to 2021","volume":"246","author":"Romero","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100255_bib66","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/23251042.2022.2031513","article-title":"Multiply-deserted areas: environmental racism and food, pharmacy, and greenspace access in the Urban South","volume":"8","author":"Satcher","year":"2022","journal-title":"Environ. Socio"},{"key":"10.1016\/j.dadr.2024.100255_bib67","doi-asserted-by":"crossref","DOI":"10.5888\/pcd20.220316","article-title":"Spatiotemporal Trends in Three Smoothed Overdose Death Rates in US Counties, 2012\u20132020","volume":"20","author":"Saunders","year":"2023","journal-title":"Prev. Chronic Dis."},{"key":"10.1016\/j.dadr.2024.100255_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2023.116417","article-title":"Residential segregation and Black-White differences in physical and mental health: evidence of a health paradox?","volume":"340","author":"Smith","year":"2024","journal-title":"Soc. Sci. Med"},{"key":"10.1016\/j.dadr.2024.100255_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2016.12.070","article-title":"Pharmacists\u2019 readiness to provide naloxone in community pharmacies in West Virginia","volume":"57","author":"Thornton","year":"2017","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.dadr.2024.100255_bib70","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/10826084.2019.1670210","article-title":"Communication Experiences of DATA-waivered physicians with community pharmacists: a qualitative study","volume":"55","author":"Ventricelli","year":"2020","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.dadr.2024.100255_bib72","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.16089","article-title":"Pharmacy availability of buprenorphine for opioid use disorder treatment in the US","volume":"6","author":"Weiner","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2024.100255_bib73","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/08897077.2022.2074604","article-title":"Commentary article: opioid use disorder cascade of care framework design: a roadmap","volume":"43","author":"Williams","year":"2022","journal-title":"Subst. Abus"},{"key":"10.1016\/j.dadr.2024.100255_bib74","article-title":"Socioeconomic and racial\/ethnic spatial polarization and incarceration among people who inject drugs in 19 US metropolitan areas, 2015","volume":"23","author":"Wise","year":"2023","journal-title":"SSM Popul Health"},{"key":"10.1016\/j.dadr.2024.100255_bib75","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s40615-020-00904-6","article-title":"Social determinants of pharmacy deserts in Los Angeles County","volume":"8","author":"Wisseh","year":"2021","journal-title":"J. Racial Ethn. Health Disparities"},{"key":"10.1016\/j.dadr.2024.100255_bib76","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.japh.2022.06.016","article-title":"Pharmacy deserts: more than where pharmacies are","volume":"62","author":"Ying","year":"2022","journal-title":"J. Am. Pharm. Assoc."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:09:49Z","timestamp":1726704589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724624000398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":73,"alternative-id":["S2772724624000398"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100255","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of economic and racial segregation with restricted buprenorphine dispensing in U.S. community pharmacies","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100255"}}